close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about ASH21

Recent news which mentions ASH21

BeyondSpring's New Plinabulin Data Shows Fast Onset In Preventing Chemo-Induced Neutropenia
Tickers BYSI
Tags why it's moving Biotech Movers
From Benzinga
Global Blood Raises $300M Via Convertible Debt Offering
Tickers GBT
Tags Market News Benzinga Small Cap
From Benzinga
Roche's Polivy Combo Boosts Survival In Early-Stage Lymphoma Patients
Tickers RHHBF RHHBY RHHVF
Tags Biotech Diffuse Large B/Cell Lymphoma General
From Benzinga
Sanofi Reveals Late-Stage Data For Fitusiran In Hemophilia Patients
Tickers SNY
Tags ASH21 hemophilia B Phase 3 Trial
From Benzinga
Agios Presents Mitapivat Long-Term Data On Hemoglobin Response, Transfusion Burden
Tickers AGIO
Tags News Health Care AGIO
From Benzinga
Precigen Reveals Early Data From CAR-T Candidate In Blood Cancer Patients
Tickers PGEN
Tags Penny Stocks Benzinga Market News
From Benzinga
Atara Bio Unveils Pivotal Data On T Cell Therapy Tabelecleucel In Transplant Patients
Tickers ATRA
Tags Briefs Health Care News
From Benzinga
Aptose Shares Fall After HM43239 Data Featured At ASH Annual Meeting, Luxeptinib, APTO-253 Update
Tickers APTO
Tags Biotech Movers General
From Benzinga
Fate Therapeutics Showcases Interim Data From FT596 Cell Program In Lymphoma
Tickers FATE
Tags Phase 1 Trial Briefs News
From Benzinga
Gilead's CAR-T Yescarta Shows 78% Complete Response Rate In First-Line Lymphoma Patients
Tickers GILD
Tags ASH21 GILD General
From Benzinga
Syndax Pharma Posts Additional Data On Clinical Activity, Responses From Early-Stage Leukemia Trial
Tickers SNDX
Tags Biotech Small Cap Market News
From Benzinga
ALX Oncology's Evorpacept Data Fails To Impress At ASH Presentation
Tickers ALXO
Tags Phase 1 Trial Health Care Phase 2 Trial
From Benzinga
Why Did X4 Pharmaceuticals Shares Crater To 52-Week Low?
Tickers XFOR
Tags Trading Ideas ASH21 General
From Benzinga
Viracta Therapeutics Posts Data From Lymphoma Trial At ASH Presentation
Tickers VIRX
Tags Phase 1 Trial News Phase 2 Trial
From Benzinga
Comparing Data: Sanofi Vs. Johnson & Johnson Multiple Myeloma Therapies In Newly Diagnosed Patients
Tickers BMY JNJ SNY TAK
Tags BMY Market News Benzinga
From Benzinga
Harpoon Shares Jump After Early Data From BCMA-Targeting Myeloma Candidate At ASH Meet
Tickers HARP
Tags Phase 2 Trial News HARP
From Benzinga
JNJ's Janssen Posts Two Years Survival Data On BCMA Cell Therapy In Multiple Myeloma
Tickers JNJ LEGN
Tags JNJ Phase 1 Trial Phase 2 Trial
From Benzinga
Jazz Posts New Data for ALL/LBL Treatment At ASH 2021 Annual Meeting
Tickers JAZZ
Tags Briefs News Phase 2 Trial
From Benzinga
Roche Uncorks Favorable Responses From Mosunetuzumab In Follicular Lymphoma Settings
Tickers RHHBF RHHBY RHHVF
Tags RHHVF Market News Benzinga
From Benzinga
New Data At ASH21 Show Bluebird's Thalassemia Gene Therapy Potentially Curative One-Time Treatment
Tickers BLUE
Tags Biotech gene therapy General
From Benzinga
Bluebird Bio Posts Updated Data From Sickle Cell Gene Therapy Program
Tickers BLUE
Tags Small Cap Market News Benzinga
From Benzinga
Gilead's Kite Unveils More Data On Yescarta In Second-Line Lymphoma Patients
Tickers GILD
Tags ASH21 Phase 3 Trial Briefs
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today